Novavax says COVID-19 vaccine 89% effective in UK trial, less in South Africa
Novavax Inc said its coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly ...